Skip to Content
Top of Page: How to talk to a doctor about advanced ovarian cancer >>

Ramucirumab Pregnancy and Breastfeeding Warnings

Ramucirumab is also known as: Cyramza

Ramucirumab Pregnancy Warnings

This drug should be used during pregnancy only if the benefit outweighs the risk. US FDA pregnancy category: C Comments: -Based on its mechanism of action, this drug may cause fetal harm. -If a patient becomes pregnant while taking this drug, she should be apprised of the potential hazard to a fetus. -Female patients should be advised to avoid getting pregnant while receiving this drug and for at least 3 months after the last dose. -Females of reproductive potential should be advised that this drug may impair fertility.

No animal studies have been conducted to evaluate the effect of the drug on reproduction and fetal development. There are no controlled data in human pregnancy. US FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.

Ramucirumab Breastfeeding Warnings

A decision should be made whether to discontinue breastfeeding or discontinue the drug, taking into account the importance of the drug to the mother. Excreted into human milk: Unknown Excreted into animal milk: Unknown Comments: -The effects in the nursing infant are unknown. -Breastfeeding should be delayed for at least three months after the last dose of this drug.

See Also...

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.